Zahi Touma, MD, PhD (@zahitouma) 's Twitter Profile
Zahi Touma, MD, PhD

@zahitouma

Rheumatologist, Director Toronto Lupus Program @UHN |
Scientist, Associate Professor @UofT @UofT_DoM | Measurement Sciences @ihpmeuoft

ID: 3829857975

linkhttps://www.uhnresearch.ca/researcher/zahi-touma calendar_today01-10-2015 03:23:55

811 Tweet

1,1K Followers

1,1K Following

José A. Gómez Puerta (@drgomezpuerta) 's Twitter Profile Photo

🆕 Just release during Lupus 2025 our review paper Dual B cell targeting in SLE: combining RTX + BELI may enhance disease control by depleting CD20 cells & blocking BLyS Beatriz Frade Sosa Juan C. Sarmiento-Monroy Ian N Bruce Laurent ARNAUD Elsevier | ScienceDirect #LUPUS kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

The Lancet Rheumatology (@thelancetrheum) 's Twitter Profile Photo

NEW for #LUPUS2025—ERN ReCONNET 🇪🇺–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic #lupus erythematosus manifestations bit.ly/3YXEmAO Free to read with registration on lancet.com (also free) Laurent ARNAUD #SLE

NEW for #LUPUS2025—<a href="/ern_reconnet/">ERN ReCONNET 🇪🇺</a>–SLICC–<a href="/SLEuroSociety/">SLEuro</a> expert consensus on the therapeutic management of rare systemic #lupus erythematosus manifestations bit.ly/3YXEmAO
Free to read with registration on lancet.com (also free)
<a href="/Lupusreference/">Laurent ARNAUD</a> #SLE
Roxana González (@roxosler) 's Twitter Profile Photo

Subclinical synovitis in #SLE is not benign, it predicts joint progression and damage. Despite unclear treatment guidelines, early detection via imaging may shift management strategies. #LUPUS2025

Subclinical synovitis in #SLE is not benign, it predicts joint progression and damage. Despite unclear treatment guidelines, early detection via imaging may shift management strategies. #LUPUS2025
The Journal of Rheumatology (@jrheum) 's Twitter Profile Photo

That’s a wrap Lupus 2025 🦋. Thank you Zahi Touma, MD, PhD and the committees for delivering a world-class program into the latest lupus and autoimmune research advancements.   Honoured to connect with globe experts and to publish the #LUPUS2025 abstracts: 🔗 jrheum.org/content/52/Sup…

That’s a wrap <a href="/LupusCongress/">Lupus 2025</a> 🦋.

Thank you <a href="/ZahiTouma/">Zahi Touma, MD, PhD</a> and the committees for delivering a world-class program into the latest lupus and autoimmune research advancements.
 
Honoured to connect with globe experts and to publish the #LUPUS2025 abstracts: 🔗 jrheum.org/content/52/Sup…
José A. Gómez Puerta (@drgomezpuerta) 's Twitter Profile Photo

Lupus 2025 concludes successfully! Excellent academic level and organization. Thanks to Zahi Touma, MD, PhD Alí Duarte, MD and all the organization for the invitation. There's not much time left until #LUPUS-CORA2027 ci vedremo presto in Florence Marta Mosca #LUPUS2025

<a href="/LupusCongress/">Lupus 2025</a> concludes successfully!
Excellent academic level and organization. 
Thanks to <a href="/ZahiTouma/">Zahi Touma, MD, PhD</a> <a href="/AliDuarteMD/">Alí Duarte, MD</a> and all the organization for the invitation. 
There's not much time left until #LUPUS-CORA2027  
ci vedremo presto in Florence <a href="/MartaMartamosca/">Marta Mosca</a> 
#LUPUS2025
GLADEL (@gladel_latam) 's Twitter Profile Photo

En #LUPUS2025 se debatieron dos enfoques para evaluar la nefritis lúpica: biopsia renal vs biopsia líquida. Moderaron por Murray B Urowitz y Laura Whittall-Garcia. Presentaron Frédéric Houssiau y Andrea Fava . #Lupus #Reumatología

En #LUPUS2025 se debatieron dos enfoques para evaluar la nefritis lúpica: biopsia renal vs biopsia líquida.
Moderaron por Murray B Urowitz y Laura Whittall-Garcia.
Presentaron Frédéric Houssiau y <a href="/andreafava/">Andrea Fava</a> .
#Lupus #Reumatología
Pankti Mehta (@panktimehta24) 's Twitter Profile Photo

What an incredible time at #lupus2025, full of learning & inspiration! Honored to present our work on: 🔸 Characterizing arthritis subtypes with a focus on type 1 interferon scores🧪 - Jaccoud's: longer disease duration, anti RNP, ⬆️ type 1 IFN - Rhupus: RF, and ⬇️ type 1 IFN

What an incredible time at #lupus2025, full of learning &amp; inspiration! 

Honored to present our work on:
🔸 Characterizing arthritis subtypes with a focus on type 1 interferon scores🧪
- Jaccoud's: longer disease duration, anti RNP, ⬆️ type 1 IFN
- Rhupus: RF, and ⬇️ type 1 IFN
Matteo Piga (@rmd_clinic) 's Twitter Profile Photo

It was an unforgettable Lupus 2025 in Toronto! Session moderations, talks, poster presentation, connecting with new and old friends! Thank you Zahi Touma, MD, PhD Alí Duarte, MD and all organisers, the wonderful Noodles Kong community and my irreplaceable crew from AOU Cagliari Università degli Studi di Cagliari 🤩

It was an unforgettable <a href="/LupusCongress/">Lupus 2025</a> in Toronto!

Session moderations, talks, poster presentation, connecting with new and old friends!

Thank you <a href="/ZahiTouma/">Zahi Touma, MD, PhD</a> <a href="/AliDuarteMD/">Alí Duarte, MD</a> and all organisers, the wonderful <a href="/lupus/">Noodles Kong</a> community and my irreplaceable crew from <a href="/AOUCagliari/">AOU Cagliari</a> <a href="/univca/">Università degli Studi di Cagliari</a> 🤩
Maria Tektonidou (@mariatektonidou) 's Twitter Profile Photo

Warm congratulations to Zahi Touma, MD, PhD and all Lupus 2025 organisers for such a successful #LUPUS2025 congress! We learned a lot, had the opportunity to share our work, meet legends from the Toronto Clinic and had the honour to co-moderate sessions with them. Thank you!

Warm congratulations to <a href="/ZahiTouma/">Zahi Touma, MD, PhD</a> and all
<a href="/LupusCongress/">Lupus 2025</a> organisers for such a successful #LUPUS2025 congress! We learned a lot, had the opportunity to share our work, meet legends from the Toronto Clinic and had the honour to co-moderate sessions with them. Thank you!
Maria Tektonidou (@mariatektonidou) 's Twitter Profile Photo

Very happy to share our review article ‘Towards precision medicine in #Antiphospholipid syndrome’ published in the #Lancet Rheumatology The Lancet Rheumatology (free access) sciencedirect.com/science/articl…

Very happy to share our review article ‘Towards precision medicine in #Antiphospholipid syndrome’ published in the #Lancet Rheumatology <a href="/TheLancetRheum/">The Lancet Rheumatology</a> (free access)
sciencedirect.com/science/articl…
Lupus 2025 (@lupuscongress) 's Twitter Profile Photo

💜 Thank you for an inspiring #LUPUS2025 in Toronto! Your passion, science & stories made it unforgettable. 📍Next stop: Florence, Italy 📅 8–11 May 2027 🦋 #LUPUS2027 + #CORA2027 🔗 Save the date 👉 lupus-cora2027.org #SLE #Rheumatology #Autoimmunity

💜 Thank you for an inspiring #LUPUS2025 in Toronto!
Your passion, science &amp; stories made it unforgettable.

📍Next stop: Florence, Italy
📅 8–11 May 2027
🦋 #LUPUS2027 + #CORA2027

🔗 Save the date 👉 lupus-cora2027.org
#SLE #Rheumatology #Autoimmunity
SLEuro (@sleurosociety) 's Twitter Profile Photo

We are excited to announce the winners of our prize draw about the Lupus Meeting in Lisbon (4-7 March 2026) with Prof. Luis Inês, President of SLEuro. 1°: Leticia Frittmann - Free Registration 2°: Nikolaos Papazoglou - 50% discount 3°: Viktoria Varga - Social Dinner Congrats!

Sindhu Johnson (@sindhujohnson5) 's Twitter Profile Photo

ANA+ People who progress ➡️to a systematic autoimmune rheumatic disease have less expression of molecules that 🛑inhibit T-cell activation. #EULAR2025 #JoanWither Zahi Touma, MD, PhD #LindaHiraki Schroeder Arthritis Institute UofT Rheumatology UHN Research

ANA+ People who progress ➡️to a systematic autoimmune rheumatic disease have less expression of molecules that 🛑inhibit T-cell activation. #EULAR2025 #JoanWither <a href="/ZahiTouma/">Zahi Touma, MD, PhD</a> #LindaHiraki <a href="/SchroederInst/">Schroeder Arthritis Institute</a> <a href="/UofTRheum/">UofT Rheumatology</a> <a href="/UHN_Research/">UHN Research</a>
Lupus Hub (@lupus_hub) 's Twitter Profile Photo

CONGRESS | #EULAR2025 | POSTER Zahi Touma, Zahi Touma, MD, PhD, University of Toronto, Department of Medicine University of Toronto, presented data from the LASER study of anifrolumab in pts with #SLE. · Significantly less organ damage accumulation with anifrolumab vs real-world SoC (HR:0.401). · Less organ damage over 10 years with

CONGRESS | #EULAR2025 | POSTER
Zahi Touma, <a href="/ZahiTouma/">Zahi Touma, MD, PhD</a>, <a href="/UofT/">University of Toronto</a>, <a href="/UofT_DoM/">Department of Medicine University of Toronto</a>, presented data from the LASER study of anifrolumab in pts with #SLE.
·  Significantly less organ damage accumulation with anifrolumab vs real-world SoC (HR:0.401).
·  Less organ damage over 10 years with